By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Arrayit today announced it is spinning out its majority-owned subsidiary Arrayit Diagnostics, which it expects to be listed on the Over-the-Counter Bulletin Board.

Arrayit will distribute its 78.18 percent interest in Arrayit Diagnostics as a stock dividend to its existing shareholders. The dividend distribution date and further details will be announced in the first quarter of 2012.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.